A significant percentage of patients with RA and ANCA positivity were also diagnosed with AAV, with GPA being the most common subtype.

An elderly patient who was initially suspected of having antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) was instead diagnosed with multiple myeloma, according to a case report ...

Relapse is common among patients with systemic polyarteritis nodosa, with mycophenolate performing similarly to cyclophosphamide.

Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today reported financial ...

Vasculitis is an autoimmune disorder that causes inflammation of the blood vessels. It can affect arteries, veins, and capillaries. This condition causes blood vessel walls to swell, which ...

George Aghjayan Hamparian welcomed Aghjayan’s leadership, stating, “Serving as ANCA’s national chairman has been one of the greatest honors of my life. Our work is not just about policy—it ...

People with vasculitis may need at least three or four vaccinations for COVID-19 before they start to show an immune response against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2 ...

A phase 1 study of ADI-001 for the treatment of lupus nephritis is now enrolling patients, and an ANCA-associated vasculitis trial is expected to begin enrollment in the second half of this year.

Other systemic disease which constitutes the primary illness, including but not limited to: eosinophilic granulomatosis with polyangiitis (EGPA), moderate to severe systemic lupus erythematosus, IgA ...

A NEW retrospective study from Japan has provided real-world insights into the efficacy and safety of avacopan, an oral C5a receptor antagonist, for antineutrophil cytoplasmic antibody ...

ANCA Vasculitis Market Outlook 2025-2035: The ANCA-Vasculitis market reached a value of USD 339 Million in 2024. Looking forward, IMARC Group expects the 7MM to reach USD 537 Million by 2035, ...